Unexpected effects of donor gender on the storage of liquid plasma

Vox Sanguinis

Volumn 93, Issue 3, 2007, Pages 223-228

  Norda, R ^a   Knutson, F ^a   Berseus, O ^b   Akerblom O ^a   Nilsson Ekdahl, K ^a   Stegmayr, B ^c   Nilsson, B ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

C1 inhibitor; Contact activation; Donor gender; Long term storage; Plasma preparation

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; FRESH FROZEN PLASMA; KALLIKREIN; PROTEIN C;

APHERESIS; ARTICLE; BLOOD CLOTTING; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAMPLING; BLOOD SMEAR; BLOOD STORAGE; CONTROLLED STUDY; DONOR SELECTION; FEMALE; HUMAN; LEUKOPENIA; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTHROMBIN TIME; SEX DIFFERENCE; THAWING;

BLOOD COAGULATION FACTORS; BLOOD DONORS; BLOOD PRESERVATION; COMPLEMENT C1 INACTIVATOR PROTEINS; FEMALE; HUMANS; KALLIKREINS; MALE; PLASMA; SERPINS; SEX FACTORS;

EID: 34548483648     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2007.00963.x     Document Type: Article

References (26)

1. Heiden M, Seitz R : Quality of therapeutic plasma-requirements for marketing authorization. Thromb Res 2002 107 : S47 S51
2. Hess JR, Hiippala S : Optimizing the use of blood products in trauma care. Crit Care 2005 9 (Suppl. 5 S10 S14
3. Johansson PI, Hansen MB, Sorensen H : Transfusion practice in massively bleeding patients: time for a change? Vox Sang 2005 89 : 92 96
4. Blomback M, Chmielewska J, Netre C, Akerblom O : Activation of blood coagulation, fibrinolytic and kallikrein systems during storage of plasma. Vox Sang 1984 47 : 355 342
5. Nilsson L, Hedner U, Nilsson IM, Robertson B : Shelf-life of bank blood and stored plasma with special reference to coagulation factors. Transfusion 1983 23 : 377 381
6. Dzik WH, Riibner MA, Linehan SK : Refreezing previously thawed fresh-frozen plasma. Stability of coagulation factors V and VIII:C. Transfusion 1989 29 : 600 604
7. Downes KA, Wilson E, Yomtovian R, Sarode R : Serial measurement of clotting factors in thawed plasma stored for 5 days. Transfusion 2001 41 : 570
8. Cardigan R, Sutherland J, Garwood M, Krailadsiri P, Seghatchian J, Beard M, Beckman N, Williamson LM : The effect of leucocyte depletion on the quality of fresh-frozen plasma. Br J Haematol 2001 114 : 233 240
9. Heiden M, Salge U, Henschler R, Pfeiffer HU, Volkers P, Hesse J, Sireis W, Seitz R : Plasma quality after whole-blood filtration depends on storage temperature and filter type. Transfus Med 2004 14 : 297 304
10. Runkel S, Haubelt H, Hitzler W, Hellstern P : The quality of plasma collected by automated apheresis and of recovered plasma from leukodepleted whole blood. Transfusion 2005 45 : 427 432
11. Cardigan R, Lawrie AS, Mackie IJ, Williamson LM : The quality of fresh-frozen plasma produced from whole blood stored at 4 °C overnight. Transfusion 2005 45 : 1342 1348
12. Mutschler DK, Larsson AO, Basu S, Nordgren A, Eriksson MB : Effects of mechanical ventilation on platelet microparticles in bronchoalveolar lavage fluid. Thromb Res 2002 108 : 215 220
13. Suontaka AM, Silveira A, Soderstrom T, Blomback M : Occurrence of cold activation of transfusion plasma during storage at +4 °C. Vox Sang 2005 88 : 172 180
14. Seligsohn U, Zivelin A, Bar-Shani S : Cold-promoted activation of factor VII: is it a problem under blood bank conditions? Haemostasis 1983 13 : 186 191
15. Seligsohn U, Zivelin A, Zwang E, Bar-Shani S : Factor VII in plasma of women taking oral contraceptives. Lack of cold activation under blood bank conditions. Transfusion 1984 24 : 171 172
16. Mackie IJ, Gallimore M, Machin SJ : Contact factor proteases and the complexes formed with α 2-macroglobulin can interfere in protein C assays by cleaving amidolytic substrates. Blood Coagul Fibrinolysis 1992 3 : 589 595
17. Mitropoulos KA, Martin JC, Stirling Y, Morrisey JH, Cooper JA : Activation of factors XII and VII induced in citrated plasma in the presence of contact surface. Thromb Res 1995 78 : 67 75
18. Colman RW : Biologic activities of the contact factors in vivo - potentiation of hypotension, inflammation, and fibrinolysis, and inhibition of cell adhesion, angiogenesis and thrombosis. Thromb Haemost 1999 82 : 1568 1577
19. Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI : Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest 1979 64 : 1056 1065
20. Laake K, Vennerod AM, Haugen G, Gjonnaess H : Cold-promoted activation of factor VII in human plasma: studies on the associated acyl-arginine esterase activity. Thromb Res 1974 4 : 769 785
21. Laake K, Gjonnaess H, Fagerhol MK : Components of the kallikrein-kinin system and the spontaneous cold activation of factor VII in human plasma. Acta Pharmacol Toxicol (Copenh) 1973 33 : 229 240
22. van Royen EA, Lohman S, Voss M, Pondman KW : C-1 inactivator and cold-promoted activation of factor VII. J Lab Clin Med 1978 92 : 152 163
23. Farsetti A, Narducci M, Moretti F, Nanni S, Mantovani R, Sacchi A, Pontecorvi A : Inhibition of ERα-mediated trans-activation of human coagulation factor XII gene by heteromeric transcription factor NF-Y. Endocrinology 2001 142 : 3380 3388
24. Davis AE, 3rd. : Biological effects of C1 inhibitor. Drug News Perspect 2004 17 : 439 446
25. Cobain TJ, Vamvakas EC, Wells A, Titlestad K : A survey of the demographics of blood use. Transfus Med 2007 17 : 1 15
26. Caliezi C, Zeerleder S, Redondo M, Regli B, Rothen HU, Zurcher-Zenklusen R, Rieben R, Devay J, Hack CE, Lammle B, Wuillemin WA : C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction. Crit Care Med 2002 30 : 1722 1728